Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

PARP rivals close in on AZ and Merck’s market leading Lynparza

Unlocking the potential of connected commercialisation solutions

Considerations for Mobile Health Technology Developers: Part 2

Novo Nordisk achieve headline results with icodec insulin

Roche gets FDA approval for HER2 breast cancer diagnostic

Parsortix

Parsortix_device

Market Access/ News/ News/ News/ Oncology

Angle claims FDA okay for Parsortix liquid biopsy system

Phil Taylor Angle, breast cancer, diagnosis, liquid biopsy, Oncology, Parsortix, regulatory approval 0 Comment

After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic

X

Angle claims FDA okay for Parsortix liquid biopsy system

https://pharmaphorum.com/news/angle-claims-fda-okay-for-parsortix-liquid-biopsy-system/

parsortix2

News/ News/ Oncology

Angle produces new data backing liquid biopsy in cancer

Richard Staines cancer, diagnostics, Parsortix, R&D 0 Comment

Angle hopes Parsortix will be first approved cell-based liquid biopsy.

X

Angle produces new data backing liquid biopsy in cancer

https://pharmaphorum.com/news/angle-produces-new-data-backing-liquid-biopsy-cancer/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Amylyx ALS drug draws criticism over $158,000 price tag
Translarna not approved by NICE for DMD on NHS
Roche gets FDA approval for HER2 breast cancer diagnostic
AstraZeneca pays record 660% premium for gene editing company LogicBio
Novo Nordisk achieve headline results with icodec insulin

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com